Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures-Reference-Cited by-同舟云学术

Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures

Published:2022-06-10 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Haradanhalli Ravish S.¹^ORCID,Fotedar Nidhi¹,Kumari Nitu²^ORCID,Narayana D. H. Ashwath¹

Affiliation:

1. Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore, India

2. Department of Community Medicine, Bangalore Medical College & Research Institute, Bangalore, India

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2081024

Reference26 articles.

1. WHO Expert Consultation on Rabies. Third report, technical report series 1012. Geneva: World Health Organization; 2018.

2. Four Thousand Years of Concepts Relating to Rabies in Animals and Humans, Its Prevention and Its Cure

3. World Health Organization. WHO South East Asia Region: Strategic framework for elimination of human rabies transmitted by dogs in the South–East Asia region. Regional Office for South East Asia, World Health Organization; 2012.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demographic, temporal, and spatial analysis of human rabid animal bite cases in Mymensingh District, Bangladesh;2024-05-13

2. Post-Marketing Surveillance of the World’s First Novel Cocktail of Rabies Monoclonal Antibodies: TwinRab™ in Real \-World Setting;Indian Journal of Community Medicine;2024-03

3. Ptosis Caused by Local Injection of Human Rabies Immunoglobulin;Journal of Craniofacial Surgery;2024-02-12

4. Pediatric Long Bone Fractures After Dog Bites: A Case Series and Systematic Review;Cureus;2023-10-17

5. Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus;Expert Opinion on Drug Safety;2023-07-12